Collateralizing ventral subiculum melanocortin 4 receptor circuits regulate energy balance and food motivation

Singh, Uday; Saito, Kenji; Khan, Michael Z.; Jiang, Jingwei; Toth, Brandon A.; Rodeghiero, Samuel R.; Dickey, Jacob E.; Deng, Yuting; Deng, Guorui; Kim, Young-Cho; Cui, Huxing

doi:10.1016/j.physbeh.2023.114105

Cited by 1 publication

(1 citation statement)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Melanocortin 4 receptor (MC4R), a member of the G protein-coupled receptor family and with alpha-melanocyte-stimulating hormone (a-MSH) as its ligand, is mainly distributed in the ventromedial hypothalamus and is a crucial modulator of food intake and energy homeostasis ( 13 ). Human MC4R gene is situated at the 18q21 region of chromosome 18.…”

Section: Introductionmentioning

confidence: 99%

The rs17782313 polymorphism near MC4R gene confers a high risk of obesity and hyperglycemia, while PGC1α rs8192678 polymorphism is weakly correlated with glucometabolic disorder: a systematic review and meta-analysis

Zhang

Nie

et al. 2023

Front. Endocrinol.

View full text Add to dashboard Cite

BackgroundThe relationships of the rs17782313 polymorphism near melanocortin 4 receptor gene (MC4R) and the rs8192678 polymorphism in peroxisome proliferator-activated receptor gamma coactivator 1 alpha gene (PGC1α) with metabolic abnormalities have been explored in many populations around the world, but the findings were not all consistent and sometimes even a bit contradictory.MethodsElectronic databases including Medline, Scopus, Embase, Web of Science, CNKI and Google Scholar were checked for studies that met the inclusion criteria. Data were carefully extracted from eligible studies. Standardized mean differences (SMDs) were calculated by using a random-effects model to examine the differences in the indexes of obesity, glucometabolic disorder and dyslipidemia between the genotypes of the rs17782313 and rs8192678 polymorphisms. Cochran’s Q-statistic test and Begg’s test were employed to identify heterogeneity among studies and publication bias, respectively.ResultsFifty studies (58,716 subjects) and 51 studies (18,660 subjects) were respectively included in the pooled meta-analyses for the rs17782313 and rs8192678 polymorphisms. The C-allele carriers of the rs17782313 polymorphism had a higher average level of body mass index (SMD = 0.21 kg/m2, 95% confidence interval [95% CI] = 0.12 to 0.29 kg/m2, p < 0.001), waist circumference (SMD = 0.14 cm, 95% CI = 0.06 to 0.23 cm, p < 0.001) and blood glucose (SMD = 0.09 mg/dL, 95% CI = 0.02 to 0.16 mg/dL, p = 0.01) than the TT homozygotes. Regarding the rs8192678 polymorphism, no significant associations with the indexes of obesity, glucometabolic disorder and dyslipidemia were detected. However, significant correlations between the rs8192678 polymorphism and multiple glucometabolic indexes were observed in subgroup analyses stratified by sex, age, ethnicity and health status.ConclusionThe meta-analysis demonstrates that the C allele of the MC4R rs17782313 polymorphism confers a higher risk of obesity and hyperglycemia, and the PGC1α rs8192678 polymorphism is weakly correlated with glucometabolic disorder. These findings may partly explain the relationships between these variants and diabetes as well as cardiovascular disease.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42022373543.

show abstract

Section: Introductionmentioning

confidence: 99%